504 related articles for article (PubMed ID: 19564142)
21. Polyisoprene matrix for progesterone release: in vitro and in vivo studies.
Heredia V; Bianco ID; Tríbulo H; Tríbulo R; Seoane MF; Faudone S; Cuffini SL; Demichelis NA; Schalliol H; Beltramo DM
Int J Pharm; 2009 Dec; 382(1-2):98-103. PubMed ID: 19699285
[TBL] [Abstract][Full Text] [Related]
22. Correlation between the FT-IR characteristics and metoprolol tartrate release of methylcellulose-based patches.
Papp J; Horgos J; Szente V; Zelkó R
Int J Pharm; 2010 Jun; 392(1-2):189-91. PubMed ID: 20371276
[TBL] [Abstract][Full Text] [Related]
23. An investigation into effects of in vitro test condition on the release properties of theophylline from HPMC matrices using factorial design.
Petrovic A; Ibric S; Trajkovic S; Popovic R; Djuric Z; Popadic D
Arch Pharm Res; 2009 Jul; 32(7):1087-96. PubMed ID: 19641891
[TBL] [Abstract][Full Text] [Related]
24. [Description of the release of sodium ferulate from hydroxypropyl methylcellulose based matrix tablets in vitro].
Li FQ; Hu JH
Yao Xue Xue Bao; 2004 May; 39(5):389-91. PubMed ID: 15338886
[TBL] [Abstract][Full Text] [Related]
25. Formulation development, in vitro and in vivo evaluation of membrane controlled transdermal systems of glibenclamide.
Mutalik S; Udupa N
J Pharm Pharm Sci; 2005 Jan; 8(1):26-38. PubMed ID: 15946595
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
[TBL] [Abstract][Full Text] [Related]
27. Characterization and drug release investigation of amorphous drug-hydroxypropyl methylcellulose composites made via supercritical carbon dioxide assisted impregnation.
Gong K; Rehman IU; Darr JA
J Pharm Biomed Anal; 2008 Dec; 48(4):1112-9. PubMed ID: 18922658
[TBL] [Abstract][Full Text] [Related]
28. Crystallinity evaluation of tacrolimus solid dispersions by chemometric analysis.
Zidan AS; Rahman Z; Sayeed V; Raw A; Yu L; Khan MA
Int J Pharm; 2012 Feb; 423(2):341-50. PubMed ID: 22100517
[TBL] [Abstract][Full Text] [Related]
29. Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method.
Jelvehgari M; Atapour F; Nokhodchi A
Arch Pharm Res; 2009 Jul; 32(7):1019-28. PubMed ID: 19641883
[TBL] [Abstract][Full Text] [Related]
30. Designing bioresorbable polyester matrices for controlled doxorubicin release in glioma therapy.
Kasperczyk J; Stoklosa K; Dobrzynski P; Stepien K; Kaczmarczyk B; Dzierzega-Lecznar A
Int J Pharm; 2009 Dec; 382(1-2):124-9. PubMed ID: 19715746
[TBL] [Abstract][Full Text] [Related]
31. Microwave non-destructive testing technique for characterization of HPMC-PEG 3000 films.
Wong TW; Deepak KG; Taib MN; Anuar NK
Int J Pharm; 2007 Oct; 343(1-2):122-30. PubMed ID: 17597317
[TBL] [Abstract][Full Text] [Related]
32. Eudragit RS 100 microparticles containing 2-hydroxypropyl-beta-cyclodextrin and glutathione: physicochemical characterization, drug release and transport studies.
Trapani A; Laquintana V; Denora N; Lopedota A; Cutrignelli A; Franco M; Trapani G; Liso G
Eur J Pharm Sci; 2007 Jan; 30(1):64-74. PubMed ID: 17118631
[TBL] [Abstract][Full Text] [Related]
33. Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications.
Sievens-Figueroa L; Bhakay A; Jerez-Rozo JI; Pandya N; Romañach RJ; Michniak-Kohn B; Iqbal Z; Bilgili E; Davé RN
Int J Pharm; 2012 Feb; 423(2):496-508. PubMed ID: 22178619
[TBL] [Abstract][Full Text] [Related]
34. Gastroretentive drug delivery systems with L-dopa based on carrageenans and hydroxypropylmethylcellulose.
Dorożyński P; Kulinowski P; Mendyk A; Jachowicz R
Int J Pharm; 2011 Feb; 404(1-2):169-75. PubMed ID: 21095225
[TBL] [Abstract][Full Text] [Related]
35. Delivery of ethinylestradiol from film forming polymeric solutions across human epidermis in vitro and in vivo in pigs.
Zurdo Schroeder I; Franke P; Schaefer UF; Lehr CM
J Control Release; 2007 Apr; 118(2):196-203. PubMed ID: 17289207
[TBL] [Abstract][Full Text] [Related]
36. Sustained delivery of captopril from floating matrix tablets.
Jiménez-Martínez I; Quirino-Barreda T; Villafuerte-Robles L
Int J Pharm; 2008 Oct; 362(1-2):37-43. PubMed ID: 18588962
[TBL] [Abstract][Full Text] [Related]
37. Design and in vitro and in vivo characterization of mucoadhesive matrix pellets of metformin hydrochloride for oral controlled release: a technical note.
Ige PP; Gattani SG
Arch Pharm Res; 2012 Mar; 35(3):487-98. PubMed ID: 22477196
[TBL] [Abstract][Full Text] [Related]
38. The influence of Metolose structure on the free volume and the consequent metoprolol tartrate release of patches.
Papp J; Marton S; Süvegh K; Zelkó R
Int J Biol Macromol; 2009 Jan; 44(1):6-8. PubMed ID: 18940196
[TBL] [Abstract][Full Text] [Related]
39. A drug-in-adhesive transdermal patch for S-amlodipine free base: in vitro and in vivo characterization.
Sun Y; Fang L; Zhu M; Li W; Meng P; Li L; He Z
Int J Pharm; 2009 Dec; 382(1-2):165-71. PubMed ID: 19716871
[TBL] [Abstract][Full Text] [Related]
40. Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate.
Ambrogi V; Perioli L; Marmottini F; Giovagnoli S; Esposito M; Rossi C
Eur J Pharm Sci; 2007 Nov; 32(3):216-22. PubMed ID: 17826966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]